McKesson (NYSE: MCK) sets Q4 2026 earnings call and investor conferences
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
McKesson Corporation filed an 8‑K to share investor relations updates. The company will release its fourth quarter fiscal 2026 results after market close on May 7, 2026, followed by an earnings conference call and live webcast at 4:30 PM Eastern Time.
Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host the call. McKesson also reaffirmed its fiscal 2026 full year outlook, consistent with guidance issued on February 4, 2026, and highlighted Mr. Vitalone’s participation in several major healthcare investor conferences, with webcasts available on its investor relations website.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 6, 2026
(Exact Name of Registrant as Specified in Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of Principal Executive Offices, and Zip Code)
(972 ) 446-4800
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
On March 6, 2026, the company issued the news release attached to this report as Exhibit 99.1.
Item 9.01 | Financial Statements and Exhibits. | ||||
(d) Exhibits.
| Exhibit No. | Description | |||||||
| 99.1 | News release issued by McKesson Corporation on March 6, 2026 | |||||||
| 104 | Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 6, 2026
| McKesson Corporation | ||||||||
| By: | /s/ Britt J. Vitalone | |||||||
Britt J. Vitalone | ||||||||
Executive Vice President and | ||||||||
Chief Financial Officer | ||||||||
Exhibit 99.1
MCKESSON CORPORATION ANNOUNCES FOURTH QUARTER FISCAL 2026 EARNINGS RELEASE DATE AND PARTICIPATION IN UPCOMING CONFERENCES
IRVING, Texas, March 6, 2026 -- McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.
McKesson Corporation has reaffirmed fiscal 2026 full year outlook as previously issued on February 4, 2026.
The live webcast for each event will be available on McKesson’s Investor Relations website.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.
We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events.
Contacts
Investors
Investors@McKesson.com
FAQ
When will McKesson (MCK) report fourth quarter fiscal 2026 earnings?
McKesson will release its fourth quarter fiscal 2026 results after market close on May 7, 2026. A live webcast earnings conference call at 4:30 PM Eastern Time the same day will review the company’s financial performance and outlook.
What time is McKesson’s Q4 fiscal 2026 earnings conference call?
McKesson’s fourth quarter fiscal 2026 earnings conference call starts at 4:30 PM Eastern Time on May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host the webcast for investors on the company’s investor relations website.
Has McKesson (MCK) changed its fiscal 2026 full year outlook?
McKesson has reaffirmed its fiscal 2026 full year outlook as previously issued on February 4, 2026. This means the company is maintaining the same guidance communicated earlier, signaling consistency in its expectations for the current fiscal year.
Which investor conferences will McKesson’s CFO attend in 2026?
Chief Financial Officer Britt Vitalone will participate in the Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on March 11, 2026. He will also take part in the BofA Securities 2026 Healthcare Conference in May 2026, with webcasts available online.
Where can investors access McKesson’s earnings and conference webcasts?
Investors can access live webcasts for McKesson’s earnings call and conference presentations on the company’s investor relations website. McKesson routinely posts information there, including business developments, earnings, financial performance updates, and materials for upcoming and past investor events.
What does McKesson’s March 6, 2026 8-K primarily disclose?
The March 6, 2026 8-K primarily discloses the scheduled release date and call time for McKesson’s Q4 fiscal 2026 results, reaffirmation of its full year 2026 outlook, and upcoming investor conference participation by CFO Britt Vitalone, all supported by an accompanying investor news release.